课题基金 / 基金详情

PRESYNAPTIC DOPAMINE MECHANISMS AFTER CHRONIC COCAINE

PRESYNAPTIC DOPAMINE MECHANISMS AFTER CHRONIC COCAINE
慢性可卡因后的突触前多巴胺机制
批准号:
6329148
负责人:
EVERETT H ELLINWOOD
金额:
$24.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-02-01 至 2002-11-30

项目摘要

项目成果

EVERETT H ELLINWOOD的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Applicant's Abstract) Several literature reviews have examined tolerance and sensitization in the extended cocaine abuse withdrawal syndrome, and its relevance for recidivism. However, the potential for manipulating mechanisms underlying tolerance and sensitization for therapeutic purposes remains unclear. Our goal in this project is to examine the mechanisms underlying chronic cocaine tolerance at one week after withdrawal. Our focus is on an examination of the robust presynaptic dopamine autoreceptor mechanisms, along with parallel assessment of changes in dopamine reuptake parameters. Rats made tolerant by continuous cocaine administration will be compared with two control groups: 1) a positive drug control group made supersensitive to the behavioral effects of cocaine by daily intermittent injections of the same daily dose, and 2) saline controls. Our previous studies have established that tolerance extends out to at least seven days of withdrawal and is accompanied by dopamine autoreceptor supersensitivity as measured by several different methods ranging from behavioral, to in vitro HPLC and voltammetric, to antisense ODN probes. We are now proposing a set of experiments that further, and more extensively, characterize dopamine autoreceptor function during withdrawal from continuous or intermittent cocaine administration, using these same methods: 1) Behavior to examine the functional consequences of autoreceptor supersensitivity, 2) Voltammetry, with its ultra-fast temporal and spatial resolution allows for the assessment of both DA release and reuptake parameters in specific, localized brain areas, and 3) Antisense ODN's to reduce messenger RNA transcription of DA D2 receptors, to further assess the ODN effects on autoreceptor control of dopamine synthesis, neuronal firing rates, and dopamine mediated behaviors.
期刊论文(20)
专著(0)
科研奖励(0)
会议论文
Altered activity of midbrain dopamine neurons following 7-day withdrawal from chronic cocaine abuse is normalized by D2 receptor stimulation during the early withdrawal phase.
慢性可卡因滥用戒断 7 天后,中脑多巴胺神经元的活动改变通过早期戒断阶段 D2 受体刺激而正常化。
DOI: 10.1016/s0893-133x(99)00011-1
发表时间: 1999
期刊: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
影响因子: --
作者: [Lee,TH, Gao,WY, Davidson,C, Ellinwood,EH]
通讯作者: Ellinwood,EH
Ondansetron, given during the acute cocaine withdrawal, attenuates oral cocaine self-administration.
在急性可卡因戒断期间给予昂丹司琼,可减弱口服可卡因的自我给药。
DOI: 10.1016/j.ejphar.2004.09.041
发表时间: 2004
期刊: European journal of pharmacology
影响因子: 5
作者: [Davidson,Colin, Lazarus,Cindy, Lee,TongH, Ellinwood,EverettH]
通讯作者: Ellinwood,EverettH
Time-dependent changes in nicotine behavioral responsivity during early withdrawal from chronic cocaine administration and attenuation of cocaine sensitization by mecamylamine.
在早期戒除长期可卡因给药和美加明减弱可卡因致敏过程中,尼古丁行为反应性发生时间依赖性变化。
DOI: 10.1016/j.bbr.2013.12.051
发表时间: 2014
期刊: Behavioural brain research
影响因子: 2.7
作者: [Szabo,StevenT, Fowler,JC, Froeliger,Brett, Lee,TongH]
通讯作者: Lee,TongH
Differential time-course profiles of dopamine release and uptake changes induced by three dopamine uptake inhibitors.
三种多巴胺摄取抑制剂诱导的多巴胺释放和摄取变化的不同时程曲线。
DOI: 10.1002/syn.1087
发表时间: 2001
期刊: Synapse (New York, N.Y.)
影响因子: --
作者: [Lee,TH, Balu,R, Davidson,C, Ellinwood,EH]
通讯作者: Ellinwood,EH
12
    Medication Development for Methanphetamine Abuse
    • 批准号:
      6365472
    • 项目类别:
    • 资助金额:
      $34.65万
    • 财政年份:
      2001
    • 负责人:
      EVERETT H ELLINWOOD
    • 依托单位:
    Medication Development for Methanphetamine Abuse
    • 批准号:
      6634379
    • 项目类别:
    • 资助金额:
      $30.8万
    • 财政年份:
      2001
    • 负责人:
      EVERETT H ELLINWOOD
    • 依托单位:
    Medication Development for Methanphetamine Abuse
    • 批准号:
      6911540
    • 项目类别:
    • 资助金额:
      $34.65万
    • 财政年份:
      2001
    • 负责人:
      EVERETT H ELLINWOOD
    • 依托单位:
    Medication Development for Methanphetamine Abuse
    • 批准号:
      6515915
    • 项目类别:
    • 资助金额:
      $30.8万
    • 财政年份:
      2001
    • 负责人:
      EVERETT H ELLINWOOD
    • 依托单位:
    海外基金